BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33323410)

  • 1. Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.
    Abd-Elrahman KS; Albaker A; de Souza JM; Ribeiro FM; Schlossmacher MG; Tiberi M; Hamilton A; Ferguson SSG
    Sci Signal; 2020 Dec; 13(662):. PubMed ID: 33323410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease.
    Hamilton A; Esseltine JL; DeVries RA; Cregan SP; Ferguson SS
    Mol Brain; 2014 May; 7():40. PubMed ID: 24886239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
    Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
    J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models.
    Abd-Elrahman KS; Hamilton A; Vasefi M; Ferguson SSG
    Mol Brain; 2018 Apr; 11(1):19. PubMed ID: 29631635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease.
    Abd-Elrahman KS; Ferguson SSG
    Annu Rev Pharmacol Toxicol; 2022 Jan; 62():235-254. PubMed ID: 34516293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
    Hamilton A; Vasefi M; Vander Tuin C; McQuaid RJ; Anisman H; Ferguson SS
    Cell Rep; 2016 May; 15(9):1859-65. PubMed ID: 27210751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease.
    Haas LT; Strittmatter SM
    J Biol Chem; 2016 Aug; 291(33):17112-21. PubMed ID: 27325698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
    Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
    Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM; Kostylev MA; Lee S; Strittmatter SM
    J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mGluR5/PI3K-AKT Pathway Alleviates Alzheimer's Disease-Like Pathology Through the Activation of Autophagy in 5XFAD Mice.
    Chen Y; Zhang Y; Chen Q; Liu Y; Wei X; Wu M; Zhang K; Liu Y; Wei W
    J Alzheimers Dis; 2023; 91(3):1197-1214. PubMed ID: 36565127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.
    Haas LT; Salazar SV; Smith LM; Zhao HR; Cox TO; Herber CS; Degnan AP; Balakrishnan A; Macor JE; Albright CF; Strittmatter SM
    Cell Rep; 2017 Jul; 20(1):76-88. PubMed ID: 28683325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors.
    Shrivastava AN; Kowalewski JM; Renner M; Bousset L; Koulakoff A; Melki R; Giaume C; Triller A
    Glia; 2013 Oct; 61(10):1673-86. PubMed ID: 23922225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
    Brody AH; Strittmatter SM
    Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ pathology downregulates brain mGluR5 density in a mouse model of Alzheimer.
    Lee M; Lee HJ; Park IS; Park JA; Kwon YJ; Ryu YH; Kim CH; Kang JH; Hyun IY; Lee KC; Choi JY
    Neuropharmacology; 2018 May; 133():512-517. PubMed ID: 29427650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
    J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid β oligomers suppress excitatory transmitter release via presynaptic depletion of phosphatidylinositol-4,5-bisphosphate.
    He Y; Wei M; Wu Y; Qin H; Li W; Ma X; Cheng J; Ren J; Shen Y; Chen Z; Sun B; Huang FD; Shen Y; Zhou YD
    Nat Commun; 2019 Mar; 10(1):1193. PubMed ID: 30867420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.